Neurotoxicity by Cefepime: Case-Control Study

Background: Cefepime is a fourth-generation cephalosporin widely used for empiric treatment of severe infections. Neurotoxicity by cefepime have been reported due to γ-aminobutyric acid A receptor inhibition or other mechanisms. The aim of this study was to evaluate the risk factors for cefepime-ind...

Full description

Bibliographic Details
Main Authors: Joong Koo Kang, Soon Bae Kim
Format: Article
Language:English
Published: The Korean Neurocritical Care Society 2014-12-01
Series:Journal of Neurocritical Care
Subjects:
Online Access:http://www.e-jnc.org/upload/pdf/jnc-7-2-104.pdf